Our patented technology represents a potential long‐term therapeutic approach for the prevention of hypoglycemia. We are currently seeking new investors and development partners.
If you are interested in exploring investment or partnership opportunities with Zucara Therapeutics, please contact:
Michael Midmer, CEO
1300-661 University Ave.
Toronto, ON M5G 0B7